Analytical Data
-
基因名
RDH11
- Application
-
别名
Androgen-regulated short-chain dehydrogenase/reductase 1HCV core-binding protein HCBP12;Prostate short-chain dehydrogenase/reductase 1Retinal reductase 1 ;RalR1Short chain dehydrogenase/reductase family 7C member 1
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TC12
-
表达区间
22-318aa
-
分子量
49 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RDH11, or Retinol Dehydrogenase 11, is a key enzyme involved in the metabolism of retinoids, which are essential for various biological processes including vision, cell differentiation, and embryonic development. The protein plays a critical role in the conversion of retinol (vitamin A) into active retinaldehyde, influencing the availability of retinoids for vital physiological functions. Research into RDH11 has gained traction due to its potential implications in developmental disorders, cancer progression, and other diseases linked to retinoid metabolism. Moreover, understanding the structural and functional properties of RDH11 could pave the way for therapeutic strategies targeting retinoid-related pathways. Recombinant RDH11 protein production allows scientists to study its enzymatic activity, interaction with retinoids, and its regulation under different physiological conditions. By characterizing this protein in vitro and in animal models, researchers aim to elucidate its precise role in health and disease, which may offer new insights for drug development and personalized medicine approaches in treating conditions associated with retinoid dysregulation. Thus, RDH11 not only serves as a vital tool in developmental biology but also holds promise as a target for future therapeutic interventions.
